KAY LYNN DARBY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FINDLAY, OH NPI 1780139360
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner OH Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,134.22
- Category: General Payments
- Program years: PY2021–2024
- Record count: 46
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $153.45 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $149.30 | 7 |
| Education | $4.15 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $38.31 | 2 |
| Retrophin, Inc. | $30.58 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.33 | 1 |
| Mallinckrodt Hospital Products Inc. | $22.15 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.49 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.59 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086304235 | Bayer Healthcare Pharmaceuticals Inc. | $24.33 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086937495 | Novartis Pharmaceuticals Corporation | $20.49 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104335226 | AstraZeneca Pharmaceuticals LP | $19.14 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105349826 | AstraZeneca Pharmaceuticals LP | $19.17 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119054668 | Otsuka America Pharmaceutical, Inc. | $17.59 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145165008 | Mallinckrodt Hospital Products Inc. | $22.15 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149886019 | Travere Therapeutics, Inc. | $4.15 | 08/19/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1149886023 | Travere Therapeutics, Inc. | $26.43 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.